Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Inks Deal with GenoSplice for Transcriptome Informatics

NEW YORK (GenomeWeb News) – Affymetrix today said that it has signed a co-marketing agreement with GenoSplice naming the Evry, France-based bioinformatics firm as its preferred data analysis service provider for the GeneChip Human Transcriptome Array 2.0.

Affy noted that GenoSplice's Easana expression analysis product, which can analyze data from the firm's microarrays including its GeneChip Exon 1.0 ST Array, the GeneChip Human Transcriptome Array 1.0 and the newer GeneChip Human Transcriptome Array 2.0.

"As part of Affymetrix's commitment to provide end-to-end solutions, we are enabling those without access to bioinformatics to utilize the most powerful microarrays ever developed for the interrogation of alternative splicing events," Kevin Cannon, SVP of the expression business unit at Affy, said in a statement.

Further terms of the alliance were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.